Ola A El-Feky

Dr. Ola A El-Feky

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
NENahla E. El-Ashmawy
Nahla E. El-Ashmawy
HEHoda A. El-Bahrawy
Hoda A. El-Bahrawy
MSMaha M. Shamloula
Maha M. Shamloula
OEOla A El-Feky
Ola A El-Feky

16 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
EEEman Mamdoh EL-Shial
Eman Mamdoh EL-Shial
AKAmal Kabbash
Amal Kabbash
MEMona El-Aasr
Mona El-Aasr
OEOla A El-Feky
Ola A El-Feky
SESuzy ElSherbeni
Suzy ElSherbeni
The rising prevalence of non-alcoholic fatty liver disease NAFLD has strained the healthcare system. Natural products could solve this problem, so the current study focused on the impact of G. thunbergia Thunb. against this ailment. LC–ESI–MS/MS revealed the phytochemical profile of the methanol extract from Gardenia thunbergia leaves (GME). Forty-eight compounds were tentatively identified, and stigmasterol, fucosterol, ursolic acid, and rutin were isolated. The separation of the last three compounds from this plant had not before been achieved. The anti-NAFLD effect of the methanol extract of the leaves of G. thunbergia, and its major metabolite, rutin, was assessed in mice against high-fructose diet (HFD)-induced obesity. Male mice were allocated into nine groups: (1) saline (control), (2) 30% fructose (diseased group), (3) HFD, and 10 mg/kg of simvastatin. Groups 4–6 were administered HFD and rutin 50, 75, and 100 mg/kg. Groups (7–9) were administered HFD and methanol extract of leaves 100, 200, and 300 mg/kg. Methanol extract of G. thunbergia leaves at 200 mg/kg, and rutin at 75 mg/kg significantly reduced HFD-induced increments in mice weight and hepatic damage indicators (AST and ALT), steatosis, and hypertrophy. The levels of total cholesterol, LDL–C, and triglycerides in the blood decreased. In addition, the expressions of CYP2E1, JNK1, and iNOS in the diseased mice were downregulated. This study found that GME and rutin could ameliorate NAFLD in HFD-fed mice, with results comparable to simvastatin, validating G. thunbergia’s hepatoprotective effects.

27 October 2018 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
NEN. E. El-Ashmawy
N. E. El-Ashmawy
EEE. A. El-Zamarany
E. A. El-Zamarany
EKE. G. Khedr
E. G. Khedr
HEH. A. El-Bahrawy
H. A. El-Bahrawy
OEOla A El-Feky
Ola A El-Feky

24 July 2024 in Gene
Verified
Journal Article
Closed access
IEIbrahim M. Elazab
Ibrahim M. Elazab
OEOla A El-Feky
Ola A El-Feky
EKEman G. Khedr
Eman G. Khedr
NENahla E. El-Ashmawy
Nahla E. El-Ashmawy

30 July 2018 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
NENahla E. El-Ashmawy
Nahla E. El-Ashmawy
EEEnas A. El-Zamarany
Enas A. El-Zamarany
EKEman G. Khedr
Eman G. Khedr
HEHoda A. El-Bahrawy
Hoda A. El-Bahrawy
OEOla A El-Feky
Ola A El-Feky

13 May 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
EAEman A. Amr
Eman A. Amr
OEOla A El-Feky
Ola A El-Feky
EKEman G. Khedr
Eman G. Khedr
NENahla E. El-Ashmawy
Nahla E. El-Ashmawy
Background: Resistance to DOX in breast cancer (BC) treatment is attributed to multiple mechanisms. The potential of autophagy inhibition in mitigating DOX resistance in BC has yet to be clarified. Despite showing anti-tumorigenic activity, the role of ligustilide (LIG) in BC treatment remains limited. Aim: To evaluate LIG-mediated autophagy inhibition in DOX-treated MCF-7, MCF-7/DOX, and MDA-MB-231 cells, and investigate LncRNA H19’s role in BC resistance. Methods: The three cell lines were treated with DOX, LIG, or both of them. Autophagic flux and expression of ERα, metastasis-associated protein (MTA1) complex components, autophagy-related 7 gene ( ATG7 ), multidrug resistance gene 1 ( MDR1 ) and LncRNA H19 were assessed. Key findings: Both individual treatments showed dose-dependent cytotoxicity. When combined together, LIG increased DOX cytotoxicity in MCF-7/DOX and MDA-MB-231. LIG inhibited DOX-induced autophagic flux, indicated by elevated LC3BII and p62 levels, and reversed MDR1 in MCF-7/DOX and MDA-MB-231. LIG monotherapy upregulated ERα in MCF-7/DOX and restored its expression in MDA-MB-231. In MCF-7/DOX, combined treatment upregulated ERα and downregulated LncRNA H19 relative to DOX monotherapy, whereas in MDA-MB-231, it upregulated LncRNA H19 compared with DOX monotherapy. Conclusion: LIG mitigated DOX-induced resistance through inhibiting autophagy, restoring ERα expression, and downregulating LncRNA H19 in the DOX-resistant BC cell line, thereby presenting a potential therapeutic approach in BC treatment.